Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 3,226 | $314,955 | +44% | 0.06% |
| 2. | Bayforest Capital Theodoros Tsagaris | 1,594 | $155,622 | -30% | 0.07% |
| 3. | Sivik Global Healthcare Krishen Sud | 70,000 | $6,834 | -13% | 1.99% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $98.38 | 41,755 | $4,107,844.37 | 178,342 | 2025-10-01 | Filing | |
| $98.91 | 8,245 | $815,482.44 | 220,097 | 2025-10-01 | Filing | |
| $105.85 | 28,170 | $2,981,755.06 | 178,342 | 2025-09-02 | Filing | |
| $104.89 | 21,830 | $2,289,661.38 | 206,512 | 2025-09-02 | Filing | |
| $104.63 | 50,000 | $5,231,670.00 | 178,342 | 2025-08-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,884,440 | $672,127,878 | 1.55% | |
| 2. | 5,363,526 | $523,641,050 | 1.15% | |
| 3. | 4,384,369 | $428,045,966 | 0.43% | |
| 4. | 4,171,693 | $407,282,386 | 1.23% | |
| 5. | 3,118,868 | $304,495,085 | 0.44% |
News See All
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
What Makes Boston Scientific Corporation (BSX) an Investment Choice?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT
Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now.
12 Best Medical Stocks to Buy Now
On September 26, Geoff Meacham, Managing Director of Citi Research, appeared on CNBC’s “Closing Bell Overtime” to talk about President Trump’s plan to impose a 100% tariff on “all any branded...
Piper Sandler Reaffirms its Overweight Rating and $115 Price Target on Boston Scientific Corporation (BSX)
On September 25, 2025, Piper Sandler reaffirmed its Overweight rating and $115 price target on Boston Scientific Corporation (NYSE:BSX), a $145.3 billion medical products company, citing confidence in...
14 Stocks That Will Double in the Next 5 Years
Growth stocks are once again becoming popular among investors seeking long-term profits, as equity market volatility has drastically decreased.
Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval
Boston Scientific Corporation (NYSE:BSX) is emerging as a top AI-powered biotech stock by embedding artificial intelligence into its medical device portfolio, particularly in cardiology.
Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity
Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts.
Hedge Fund Resource Center Billionaire Hedge Funds
